Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03066648
Title Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | GBR | FRA | ESP | DEU | AUS

Facility Status City State Zip Country Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Oregon Health Sciences University Main Center Portland Oregon 97239 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Novartis Investigative Site Melbourne Victoria 3004 Australia Details
Novartis Investigative Site Helsinki FIN 00290 Finland Details
Novartis Investigative Site Marseille 13273 France Details
Novartis Investigative Site Dresden 01307 Germany Details
Novartis Investigative Site Jena 07740 Germany Details
Novartis Investigative Site Amsterdam 1081 HV Netherlands Details
Novartis Investigative Site Barcelona Catalunya 08036 Spain Details
Novartis Investigative Site Cardiff CF4 4XN United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field